There are more than 100 different autoimmune diseases. But what unites them all is that they arise from an individual's own cells - rare and mysterious immune cells that target not external viruses and bacteria but the body's own healthy organs and tissues.
For the first time, a team of researchers have pinpointed individual cells that cause autoimmune disease from patient samples. They also uncovered how these cells 'go rogue' by evading checkpoints that normally stop immune cells from targeting the body's own tissues.
"Current treatments for autoimmune disease address only the symptoms, but not the cause. To make more targeted treatments that address disease development and progression, we first need to understand the cause," says the co-senior author of the work published in Cell.
"We have developed a technique that allows us to look directly at the cells that cause autoimmune disease - it's as though we're looking through a new microscope lens for the first time, learning more about autoimmune disease than was ever possible before."
Because 'rogue' immune cells are so rare in a blood sample - less than one in 400 cells - studying them has been a challenge. Analysis to date has at best revealed 'averages' of the vast mix of cells in a patient's sample, says the first author of the published paper.
"Using cellular genomics, we developed a method to 'zoom in' on these disease-causing immune cells in the blood samples of four patients with cryoglobulinemic vasculitis - a severe inflammation of the blood vessels," says the author.
By first separating individual cells, and then separating their genetic material, the researchers isolated immune cells that produced 'rheumatoid factors' - antibody proteins that target healthy tissues in the body and are associated with the most common autoimmune diseases, including rheumatoid arthritis.
Once isolated, the researchers then analysed the DNA and messenger RNA of each of these 'rogue' cells, scanning more than a million positions in the genome to identify DNA variants that may be at the root of disease.
Through their analysis, the researchers discovered that the disease-causing immune cells of the vasculitis patients had accumulated a number of mutations before they produced the damaging rheumatoid factors.
"We identified step-wise genetic changes in the cells at the root of an autoimmune disease for the first time, tracing an 'evolutionary tree' of how normal immune cells develop into disease-causing cells," says the other co-senior author.
Remarkably, the researchers found that some of the first gene mutations that occurred in these rogue cells were known to drive lymphomas (cancerous immune cells).
We uncovered 'lymphoma driver mutations', including a variant of the CARD11 gene, which allowed the rogue immune cells to evade immune tolerance checkpoints and multiply unchecked," explains the co-senior author. Lymphoma driver mutations in genes regulating B cell proliferation and V(D)J mutation ( CARD11, TNFAIP3, CCND3, ID3, BTG2, and KLHL6) were present in rogue B cells producing the pathogenic autoantibody.
Further, the researchers found that cells with the lymphoma driver mutations accumulated further mutations that caused the rheumatoid factors they produced to aggregate, or 'clump together', at lower temperatures. Authors show that antibody V(D)J mutations conferred pathogenicity by causing the antigen-bound autoantibodies to undergo phase transition to insoluble aggregates at lower temperatures. These results reveal a pre-neoplastic stage in human lymphomagenesis and a cascade of somatic mutations leading to an iconic pathogenic autoantibody.
"This explains the patients' cryoglobulinemic vasculitis, a severe condition that develops in some people with Sjögren's syndrome, systemic lupus, rheumatoid arthritis, or hepatitis C virus infection. In these individuals, rheumatoid factors in the blood aggregate at colder temperatures closer to the skin and also in the kidneys, nerves, and other organs, which damages blood vessels and often proves very difficult to treat," says the author.
Not only have the research findings uncovered the root cause of an autoimmune disease - the ability to identify and investigate specific immune cells at such resolution has vast potential for future treatments to target the cause of all autoimmune diseases.
"In our study, we uncovered specific mutations that mark early stages of autoimmune disease. If we can diagnose a patient at these stages, it may be possible to combine our knowledge of these mutations with new targeted treatments for lymphoma to intervene in disease progression or to track how well a patient is responding to treatments," says the senior author.
The researchers are now planning follow-up studies to investigate mutations of autoimmune cells in a range of other diseases, including lupus, celiac disease and type 1 diabetes.
https://www.garvan.org.au/news-events/news/research-pinpoints-rogue-cells-at-root-of-autoimmune-disease
https://www.cell.com/cell/fulltext/S0092-8674(20)30110-0
Autoimmune disease producing cells contain lymphoma driver mutations
- 3,381 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
A missing link between tau and memory loss
Read more
Regulating monocyte differentiation and atherosclerosis development
Read more
Transcription factor mediated signaling in axonal regeneration
Read more
The science behind bodily secretions
Read more
A protein with power to improve heart function
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar